Xspray Pharma AB Financial Overview
Xspray Pharma AB's market cap is currently €1.04B. The company's EPS TTM is kr-1.651; its P/E ratio is -3.56; Xspray Pharma AB is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is kr1.75. See an overview of income statement, balance sheet, and cash flow financials.
